Journal Article

Immune Enhancement by the Tetra-Peptide Hydrogel as a Promising Adjuvant for an H7N9 Vaccine against Highly Pathogenic H7N9 Virus

Zhang, Lingjian, Li, Qian, Wu, Xiaoxin, Wang, Zhehua, Zhang, Fen, Zhao, Shuai, Tang, Songjia, Xiao, Lanlan, Wang, Ying, Ma, Xiaoyun, Wang, Qingjing, Chen, Keda

2022

Overview

Background: Short peptide hydrogel was reported as a possible adjuvant for vaccines. In order to evaluate whether the Tetra-Peptide Hydrogel can be a promising adjuvant for an H7N9 vaccine against the highly pathogenic H7N9 virus, we conducted this study. Methods: Tetra-Peptide Hydrogels (D and L conformations) were prepared by a self-assembly system using a Naproxen acid modified tetra peptide of GFFY (Npx-GFFY). Mice received two immunizations with the D-Tetra-Peptide Hydrogel adjuvant vaccine, the L-Tetra-Peptide Hydrogel adjuvant vaccine, or the split vaccine. Fourteen days following the second dose, the mice were challenged with the highly pathogenic A/Guangdong/GZ8H002/2017(H7N9) virus. The mice were observed for signs of illness, weight loss, pathological alterations of the lung tissues and immune responses in the following 2 weeks. Results: The D/L-Tetra-Peptide Hydrogels resembled long bars with hinges on each other, with a diameter of ~10 nm. The H7N9 vaccine was observed to adhere to the hydrogel. All the unvaccinated mice were dead by 8 days post infection with H7N9. The mice immunized by the split H7N9 vaccine were protected against infection with H7N9. Mice immunized by D/L-Tetra-Peptide Hydrogel adjuvant vaccines experienced shorter symptomatic periods and their micro-neutralization titers were higher than in the split H7N9 vaccine at 2 weeks post infection. The hemagglutinating inhibition (HI) titer in the L-Tetra-Peptide Hydrogel adjuvant vaccine group was higher than that in the split H7N9 vaccine 1 week and 2 weeks post infection. The HI titer in the D-Tetra-Peptide Hydrogel adjuvant vaccine group was higher than that in the split H7N9 vaccine at 2 weeks post infection. Conclusion: The D/L Tetra-Peptide Hydrogels increased the protection of the H7N9 vaccine and could be promising adjuvants for H7N9 vaccines against highly pathogenic H7N9 virus.

• Publisher: MDPI AG,MDPI
• Subject: adjuvant / Adjuvants / Aluminum / Antigens / Dengue fever / Encephalitis / H7N9 vaccine / Hepatitis / highly pathogenic H7N9 virus / Hydrogels / immune enhancement / Immune response / Immunization / Infections / Infectious diseases / Influenza / Laboratory animals / Lungs / Measles / Mumps / Mutation / Naproxen / Neutralization / Peptides / Poliomyelitis / R&D / Research & development / Rubella / Self-assembly / Smallpox / tetra-peptide hydrogel / Tropical diseases / Tuberculosis / Vaccines / Viruses / Weight loss / Whooping cough